Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shawn Shetty & A. Razzaque Ahmed. (2017) Rituximab in the treatment of pemphigus. Expert Opinion on Orphan Drugs 5:1, pages 99-109.
Read now
Read now
Annamaria Erdei, Gyorgy Paragh, Peter Kovacs, Zsolt Karanyi, Ervin Berenyi, Laszlo Galuska, Agota Lenkey, Lajos Szabados, Ferenc Gyory, Bernadett Ujhelyi, Andras Berta, Judit Boda, Eszter Berta, Miklos Bodor, Annamaria Gazdag & Endre V. Nagy. (2014) Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves’ orbitopathy: A five-year follow-up study. Autoimmunity 47:8, pages 548-555.
Read now
Read now
Articles from other publishers (14)
Moustafa S. Alhamadh, Thamer S. Alhowaish, Alaa Mathkour, Bayan Altamimi, Shahd Alheijani & Abdulrahman Alrashid. (2023) Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience. Clinics and Practice 13:6, pages 1286-1302.
Crossref
Crossref
Gérôme Bohelay, Frédéric Caux & Philippe Musette. (2021) Clinical and biological activity of rituximab in the treatment of pemphigus. Immunotherapy 13:1, pages 35-53.
Crossref
Crossref
A. Razzaque Ahmed & Srinivas Kaveri. (2018) Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin. Frontiers in Immunology 9.
Crossref
Crossref
Kyle Amber & Michael Hertl. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
767
774
.
Soner Uzun, Aslı Bilgiç Temel, Ayşe Akman Karakaş, Erkan Ergün, Birgül Özkesici, Ali Haydar Eskiocak, Ayşegül Erat, Nilay Uğurlu, Berna Nazlım, Saliha Koç, Selen Bozkurt, Özlem Dicle, Erkan Alpsoy & Ertan Yılmaz. (2016) Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey. International Journal of Dermatology 55:12, pages 1362-1368.
Crossref
Crossref
Wisit Cheungpasitporn, Stephen L. Kopecky, Ulrich Specks, Kharmen Bharucha & Fernando C. Fervenza. (2016) Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. Journal of Renal Injury Prevention 6:1, pages 18-25.
Crossref
Crossref
Mark Williams, Tasneem Khalid, Stephen Hughes, Denise Bonney & Robert Wynn. (2016) Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative Disease. Journal of Pediatric Hematology/Oncology 38:1, pages e29-e31.
Crossref
Crossref
Harry Alexopoulos, Angie Biba & Marinos C. Dalakas. (2015) Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials. Neurotherapeutics 13:1, pages 20-33.
Crossref
Crossref
Dana M. Hornbeak & Jennifer E. Thorne. (2015) Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention. Taiwan Journal of Ophthalmology 5:4, pages 156-163.
Crossref
Crossref
Arshia Duza Islam, Carlo Selmi, Ananya Datta-Mitra, Rebecca Sonu, Mingyi Chen, M. Eric Gershwin & Siba P. Raychaudhuri. (2015) The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis. Autoimmunity Reviews 14:10, pages 914-922.
Crossref
Crossref
A. Razzaque Ahmed & Shawn Shetty. (2015) A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab. Autoimmunity Reviews 14:4, pages 323-331.
Crossref
Crossref
Gustavo Savino, Erika Mandarà, Mariangela Gari, Remo Battendieri, Salvatore Maria Corsello & Alfredo Pontecorvi. (2014) Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy. Endocrine 48:1, pages 241-247.
Crossref
Crossref
Abdulgabar Salama. (2015) Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review. Transfusion Medicine and Hemotherapy 42:5, pages 294-301.
Crossref
Crossref
Carlo Selmi. (2014) Autoimmunity in 2013. Clinical Reviews in Allergy & Immunology 47:1, pages 100-109.
Crossref
Crossref